Martin D Madaus insider trades
Open-market stock purchases and sales by Martin D Madaus, Director at Haemonetics Corp, from SEC Form 4 filings since Feb 10, 2010.
Track record: 29% of 7 scored buys are up 5% or more since purchase, averaging -13%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 24, 2026 | HAE Haemonetics Corp | Bought (not open market) | — |
| May 14, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| May 14, 2026 | RGEN Repligen Corp | Bought (not open market) | — |
| Apr 7, 2026 | HOLX Hologic Inc | Sold (not open market) | — |
| Apr 7, 2026 | HOLX Hologic Inc | Sold (not open market) | — |
| Apr 7, 2026 | HOLX Hologic Inc | Sold (not open market) | $77K |
| Apr 7, 2026 | HOLX Hologic Inc | Sold (not open market) | $356K |
| Feb 26, 2026 | HOLX Hologic Inc | Bought (not open market) | — |
| Feb 5, 2026 | AZTA Azenta, Inc | Bought (not open market) | — |
Companies traded
- HAE Haemonetics Corp: other filings, last Jul 24, 2026
- RGEN Repligen Corp: 6 buys, last May 14, 2026
- HOLX Hologic Inc: 1 buy, last Apr 7, 2026
- AZTA Azenta, Inc: 1 buy, last Feb 5, 2026
- QTRX Quanterix Corp: 1 buy, 83 sales, last Jan 2, 2025
- LAB Standard Biotools Inc: other filings, last Oct 20, 2023
- MTD Mettler Toledo International Inc/: 1 buy, 4 sales, last Nov 18, 2014
- COV Covidien plc: other filings, last Feb 20, 2014
- MIL Millipore Corp /MA: other filings, last Jul 14, 2010